Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand

Internal Medicine Journal

Volumn 40, Issue 2, 2010, Pages 117-125

  Huggan, P J ^a,f   Wells, J E ^b   Browne, M ^d   Richardson, A ^b   Murdoch, D R ^c,e   Chambers, S T ^a,d  

^a Christchurch Hospital   (South Africa)

^b Department of Public Health and General Practice ^*  (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^e CANTERBURY HEALTH LABORATORIES   (New Zealand)

^f NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Bacteraemia; Epidemiology; Mortality; Staphylococcus aureus

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHILD; FEMALE; GROUPS BY AGE; HOSPITAL INFECTION; HOSPITAL LABORATORY; HOSPITALIZATION; HUMAN; INFANT; INFECTION RATE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MORTALITY; NEW ZEALAND; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SOCIAL STATUS; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEW ZEALAND; POPULATION SURVEILLANCE; SOCIOECONOMIC FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 77749322381     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.01910.x     Document Type: Article

References (28)

1. Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003 187 : 1452 1459.
2. Gould IM. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. Int J Antimicrob Agents 2006 28 : 379 384.
3. Collignon P, Nimmo GR, Gottlieb T, Gosbell IB, Australian Group on Antimicrobial Resistance. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005 11 : 554 561.
4. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996 23 : 255 259.
5. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006 333 : 281 286.
6. Lyytikäinen O, Ruotsalainen E, Järvinen A, Valtonen V, Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis 2005 24 : 399 404.
7. Salmond C, Crampton P, King P, Waldegrave C. NZiDep: a New Zealand index of socioeconomic deprivation for individuals. Soc Sci Med 2006 62 : 1474 1485.
8. Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in four metropolitan Connecticut areas, 1998. J Infect Dis 2001 184 : 1029 1034.
9. Danish Staphylococcus aureus Bacteraemia Group. Annual Report on Staphylococcus aureus Bacteraemia Cases. Copenhagen : Statens Serum Institute 2004 cited 2008 Jun 18]. Available from URL: http://www.ssi.dk/sw3425.asp
10. Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001 31 : 97 103.
11. Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med 2005 118 : 1416.e19 e24.
12. Thomas MG, Morris AJ. Cannula-associated Staphylococcus aureus bacteraemia: outcome in relation to treatment. Intern Med J 2005 35 : 319 330.
13. Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteraemia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003 24 : 890 896.
14. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004 364 : 703 705.
15. Page A, Tobias M, Golver J, Wright C, Hetzel D, Fisher E. Australian and New Zealand Atlas of Avoidable Mortality. Adelaide : Public Health Information Development Unit, University of Adelaide 2006.
16. Jensen J, Krishnan V, Hodgson R, Sathiyandra SG, Templeton R. New Zealand Living Standards 2004: Nga ahuatanga noho o Aotearoa. Wellington : New Zealand Ministry of Social Development 2006.
17. Robson B, Harris R, eds. Hauora: Maori Standards of Health IV. A Study of the Years 2000-2005. Wellington : Te Ropu Rangahau Hauora a Eru Pomare 2007.
18. Baker MG, Martin DR, Kieft CE, Lennon D. A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000. J Paediatr Child Health 2001 37 : S13 19.
19. Barker M, McNicholas A, Garrett N, Jones N, Stewart J, Koberstein V et al. Household overcrowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatr Infect Dis J 2000 19 : 983 990.
20. Hill PC, Wong CG, Voss LM, Taylor SL, Porrumarthy S, Drinkovic D et al. Prospective study of 125 cases of Staphylococcus aureus bacteraemia in children in New Zealand. Pediatr Infect Dis J 2001 20 : 863 873.
21. Berkman L, Epstein AM. Beyond healthcare- socioeconomic status and health. N Engl J Med 2008 358 : 2509 2510.
22. Einsiedel LJ, Fernandes LA, Woodman RJ. Racial disparities in infection-related mortality at Alice Springs Hospital, Central Australia, 2000-2005. Med J Aust 2008 188 : 568 571.
23. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002 162 : 25 32.
24. Ajwani S, Blakely T, Robson R, Atkinson J, Kiro C. Unlocking the numerator-denominator bias III: adjustment ratios by ethnicity for 1981-1999 mortality data. The New Zealand Census-Mortality Study. NZ Med J 2003 116 : 1175.
25. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008 36 : 309 332.
26. Skogberg K, Lyytikäinen O, Ruutu P, Ollgren J, Nuorti JP. Increase in bloodstream infections in Finland, 1995-2002. Epidemiol Infect 2008 136 : 108 111.
27. Collignon PJ, Wilkinson IJ, Gilbert GL, Grayson ML, Whitby RM. Health care-associated Staphylococcus aureus bloodstream infections: a clinical quality indicator for all hospitals. Med J Aust 2006 184 : 404 406.
28. The fourth year of regional and national analyses of the Department of Health's mandatory Staphylococcus aureus surveillance scheme in England. April 2001-March 2005 CDR Weekly, 15 (25). [serial on the internet] 2005 [cited 2008 Jun 19]. Available from: URL: http://www.hpa.org.uk/cdr/archives/2005/cdr2505. pdf